Hattori T, Helpap B, Gedigk P
J Cancer Res Clin Oncol. 1983;105(2):148-57. doi: 10.1007/BF00406925.
Colonic adenomas and carcinomas were induced in mice by intermittent injections of 1,2-dimethylhydrazine for 30 weeks and cell kinetic characteristics of different tumor types were studied by H-thymidine autoradiography. Labeling indices of adenomas and several carcinoma types after a single injection of H-thymidine were similar, both showing about 20%–23%. There was a tendency for the small adenomas and the poorly differentiated carcinomas to show higher labeling indices than the large adenomas and the well differentiated adenocarcinomas, respectively. By repeated injections of H-thymidine, it was shown that all adenoma and carcinoma cells became labeled within 60–70 h after the start of the injections, thereby suggesting a large growth fraction of the DMH-induced adenomas and carcinomas in the mouse colon. No remarkable differences in the labeling patterns were found between the adenomas and carcinomas, on the one hand, and intramucosal carcinomas and invasive carcinomas, on the other. The growth rate of the small adenomas appeared to be greater than that of the large adenomas and the poorly differentiated carcinomas may grow more rapidly than the well differentiated adenocarcinomas. The squamous-cell carcinomas arising in the anal region were shown to grow more rapidly than the adenocarcinomas of the colon. The changing patterns of tumor development were also studied at various times after DMH treatment with special reference to the minute neoplasms and their histogenesis and it was shown that the adenoma cells arising in the crypts accumulate in the upper part of the crypt to form an aberrant proliferative focus from which a neoplasm develops by expansion. The lesions considered to be benign on histological grounds may possibly change into adenocarcinomas of a well differentiated type. The poorly differentiated carcinomas were suggested to arise as de novo malignancy.
通过对小鼠间歇性注射1,2 - 二甲基肼30周诱导结肠腺瘤和癌,并通过H - 胸腺嘧啶核苷放射自显影研究不同肿瘤类型的细胞动力学特征。单次注射H - 胸腺嘧啶核苷后,腺瘤和几种癌类型的标记指数相似,均显示约20% - 23%。小腺瘤和低分化癌分别有比大腺瘤和高分化腺癌显示更高标记指数的趋势。通过重复注射H - 胸腺嘧啶核苷表明,在注射开始后60 - 70小时内所有腺瘤和癌细胞都被标记,从而提示在小鼠结肠中DMH诱导的腺瘤和癌有很大的生长分数。一方面,腺瘤和癌之间,另一方面,黏膜内癌和浸润性癌之间,在标记模式上未发现显著差异。小腺瘤的生长速率似乎大于大腺瘤,低分化癌可能比高分化腺癌生长得更快。发生在肛门区域的鳞状细胞癌显示比结肠腺癌生长得更快。还在DMH治疗后的不同时间特别参照微小肿瘤及其组织发生研究了肿瘤发展的变化模式,结果显示隐窝中产生的腺瘤细胞在隐窝上部积聚形成异常增殖灶,肿瘤由此通过扩展发展而来。组织学上认为是良性的病变可能会转变为高分化型腺癌。低分化癌被认为是原发恶性肿瘤。